Tang Fellowship in Cancer Immunotherapy

2020.05.05
A- | A+
Share
Plan information
Project Term: 2018-2020
Budget: NT$5 million

Origin: The Tang Prize is awarded on a biennial basis, each with a cash reward of NT$40 million. Projects proposed by the laureates also receive a grant of up to NT$10 million. The 2014 grant for Biopharmaceutical Science is shared between Dr. Allison and Prof. Honjo. 

 

Project Summary: Dr. James P. Allison decides to use his grand fund to set up a fellowship program for junior researchers in the field of cancer immunotherapy. Physician scientists and early career investigators who wish to learn about cancer immunotherapy translational research, either as clinicians who conduct cancer immunotherapy clinical trials or basic scientists who conduct immunotherapy research studies on patient samples, will be supported for one year with this award mechanism. An open competition will be held at MD Anderson Cancer Center for both incoming and existing research investigators and the center’s selection committee will appoint one research fellow each year as the recipient of this award, to whom $50,000 will be provided. At the end of the 3-year funding period, the center will have trained 3 investigators to conduct immunotherapy clinical trials or laboratory research. It is expected that each fellow will be a co-author of at least one cancer immunotherapy related manuscript, which should be in preparation by the end of the 3-year funding period.

 

Final Report: https://reurl.cc/OVjnjv